Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
Turkey · Delayed Price · Currency is TRY 31.96
-0.22 (-0.68%)
At close: Sep 26, 2025
IST:MEDTR Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,213 | 2,094 | 2,097 | 1,596 | 375.93 | 359.32 | |
Revenue Growth (YoY) | -1.96% | -0.11% | 31.40% | 324.48% | 4.62% | - |
Cost of Revenue | 1,501 | 1,307 | 1,203 | 936.41 | 216.75 | 200.96 |
Gross Profit | 712.23 | 787.5 | 894.15 | 659.33 | 159.18 | 158.36 |
Selling, General & Admin | 500.13 | 469.88 | 416.51 | 241.54 | 66.76 | 63.56 |
Research & Development | 26.77 | 23.14 | 20.07 | 6.54 | 2.45 | 0.84 |
Other Operating Expenses | 64.42 | 61.98 | 79.02 | 25.38 | 0.88 | -7.09 |
Operating Expenses | 591.32 | 554.99 | 515.6 | 273.46 | 70.09 | 57.32 |
Operating Income | 120.91 | 232.51 | 378.55 | 385.87 | 89.09 | 101.04 |
Interest Expense | -50.18 | -73.77 | -76.1 | -39.68 | -13.37 | -7.78 |
Interest & Investment Income | 68.31 | 64.08 | 220.51 | 48.87 | 19.44 | 6.49 |
Earnings From Equity Investments | -25.91 | -12.35 | -10.49 | -1.97 | -0.5 | -1.13 |
Currency Exchange Gain (Loss) | 77.52 | 102.15 | 162.13 | 190.45 | 107.6 | -10.14 |
Other Non Operating Income (Expenses) | -195.3 | -237.79 | -594.35 | -387.57 | -0.16 | 0.23 |
EBT Excluding Unusual Items | -4.65 | 74.84 | 80.26 | 195.96 | 202.1 | 88.72 |
Gain (Loss) on Sale of Investments | -1.47 | -2.24 | - | - | - | -1.91 |
Other Unusual Items | - | - | - | - | - | -21.73 |
Pretax Income | -6.12 | 72.6 | 80.26 | 195.96 | 202.1 | 65.08 |
Income Tax Expense | 72.37 | 2.28 | 42.85 | 81.66 | 34.4 | 4.65 |
Earnings From Continuing Operations | -78.49 | 70.32 | 37.41 | 114.3 | 167.7 | 60.43 |
Minority Interest in Earnings | 6.08 | 3.1 | -0.06 | 0.03 | - | - |
Net Income | -72.41 | 73.43 | 37.35 | 114.34 | 167.7 | 60.43 |
Net Income to Common | -72.41 | 73.43 | 37.35 | 114.34 | 167.7 | 60.43 |
Net Income Growth | - | 96.63% | -67.34% | -31.82% | 177.53% | - |
Shares Outstanding (Basic) | 119 | 119 | 119 | 119 | 119 | 95 |
Shares Outstanding (Diluted) | 119 | 119 | 119 | 119 | 119 | 95 |
Shares Change (YoY) | - | - | - | - | 25.93% | - |
EPS (Basic) | -0.61 | 0.62 | 0.31 | 0.96 | 1.41 | 0.64 |
EPS (Diluted) | -0.61 | 0.62 | 0.31 | 0.96 | 1.41 | 0.64 |
EPS Growth | - | 99.05% | -67.71% | -31.85% | 120.30% | - |
Free Cash Flow | 334.36 | 404.72 | 501.46 | -43.66 | 27.72 | 52.41 |
Free Cash Flow Per Share | 2.81 | 3.40 | 4.21 | -0.37 | 0.23 | 0.56 |
Dividend Per Share | - | - | 0.294 | - | - | - |
Gross Margin | 32.19% | 37.60% | 42.64% | 41.32% | 42.34% | 44.07% |
Operating Margin | 5.46% | 11.10% | 18.05% | 24.18% | 23.70% | 28.12% |
Profit Margin | -3.27% | 3.51% | 1.78% | 7.17% | 44.61% | 16.82% |
Free Cash Flow Margin | 15.11% | 19.32% | 23.92% | -2.74% | 7.38% | 14.59% |
EBITDA | 235.53 | 319.52 | 448.77 | 431.95 | 100.13 | 112.23 |
EBITDA Margin | 10.64% | 15.26% | 21.40% | 27.07% | 26.63% | 31.23% |
D&A For EBITDA | 114.62 | 87.01 | 70.22 | 46.08 | 11.04 | 11.19 |
EBIT | 120.91 | 232.51 | 378.55 | 385.87 | 89.09 | 101.04 |
EBIT Margin | 5.46% | 11.10% | 18.05% | 24.18% | 23.70% | 28.12% |
Effective Tax Rate | - | 3.14% | 53.39% | 41.67% | 17.02% | 7.15% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.